Patent: 9,540,433
✉ Email this page to a colleague
Summary for Patent: 9,540,433
Title: | Human antibodies and antibody-drug conjugates against CD74 |
Abstract: | Isolated human monoclonal antibodies which bind to human CD74 and related antibody-drug conjugates are disclosed. Pharmaceutical compositions comprising the antibodies or antibody-drug conjugates, and therapeutic and diagnostic methods for using the antibodies and/or antibody-drug conjugates, are also disclosed. |
Inventor(s): | Verploegen; Sandra (Nieuwegein, NL), Overdijk; Marije (Utrecht, NL), Dijkhuizen; Riemke Van (Zeist, NL), Bleeker; Willem Karel (Amsterdam, NL), Van Berkel; Patrick (Utrecht, NL), Parren; Paul (Odijk, NL), Lisby; Steen (Frederiksberg, DK) |
Assignee: | GENMAB A/S (Copenhagen, DK) |
Application Number: | 13/982,959 |
Patent Claims: | see list of patent claims |
Details for Patent 9,540,433
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2031-02-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |